Sipai Health Technology Co., Ltd.

Equities

314

KYG8192S1021

Drug Retailers

End-of-day quote Hong Kong S.E. 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
6.4 USD -4.62% Intraday chart for Sipai Health Technology Co., Ltd. +4.07% -7.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sipai Health Technology Expects to Narrow Loss in Full Year 2023 MT
Sipai Health Technology Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2023 CI
Sipai Health Technology Trustee Buys Back Shares MT
Sipai Health Clarifies On Public Float Confusion MT
Sipai Health Technology's Unit Becomes Controlling Shareholder of Insurance Brokerage Arm in Restructuring Plans MT
Sipai Health Technology Co., Ltd. Announces Change of Address of the Principal Place of Business CI
Sipai Health Announces Changes to Subsidiary's Shareholding Structure MT
Sipai Health Unit Inks Cooperation Deal With Shanghai Roche Pharmaceuticals MT
Sipai Health Technology Subsidiary Buys Structured Deposit Product from China Construction Bank MT
Sipai Health Technology's Unit Subscribes for Wealth Management Product Worth 340 Million Yuan MT
Sipai Health Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Sipai Health Refutes Report on JPMorgan Paring Stake in Firm MT
Sipai Health Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
Sipai Health Technology Co., Ltd. commences an Equity Buyback Plan for 76,302,531 shares, representing 10% of its issued share capital, under the authorization approved on June 30, 2023. CI
Certain Shares of Sipai Health Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 23-JUN-2023. CI
Sipai Health Technology Co., Ltd.(SEHK:314) added to S&P Global BMI Index CI
Sipai Health Technology Co., Ltd. Announces Board Changes CI
Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Sipai Health Technology Co., Ltd. Announces Change of Principal Place of Business in Hong Kong CI
Sipai Health Technology Co., Ltd. Announces Board Changes CI
China's Rising COVID Infections Breaks Hong Kong Stocks' Two-Day Gaining Spell; Fifth SPAC Untraded, Two Firms Gain in Debut MT
Sipai Health Opens 27% Higher in Hong Kong Debut MT
Sipai Health Technology Co., Ltd. has completed an IPO in the amount of HKD 184.50084 million. CI
Sipai Helath Raises HK$120 Million in Hong Kong IPO MT
Chart Sipai Health Technology Co., Ltd.
More charts
Sipai Health Technology Co Ltd is principally engaged in providing medical and health services. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
5.929 CNY
Average target price
7.893 CNY
Spread / Average Target
+33.12%
Consensus

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. 314 Stock
  4. News Sipai Health Technology Co., Ltd.
  5. Sipai Health Refutes Report on JPMorgan Paring Stake in Firm